GlassScriptPhysician profile
Niraj James Shah
NPI 1235495474
$997.03
in general payments reported to CMS, 2019-2025
10 companies · $165 in 2025
The $165 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $318 · 2020: $164 · 2021: $175 · 2023: $160 · 2024: $15.57 · 2025: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $340.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $190.63 | 2019-2021 | |
| Abbvie INC. | $181.20 | 2019-2023 | Vraylar |
| Stryker Corporation | $164.51 | 2025 | Augment Injectable |
| Janssen Biotech, INC. | $141.56 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $120.86 | 2019-2020 | |
| Novo Nordisk INC | $120.22 | 2023 | Wegovy |
| Shire North American Group INC | $25.23 | 2019 | |
| Exact Sciences Corporation | $19.76 | 2023 | Cologuard Collection Kit |
| Intercept Pharmaceuticals, INC. | $17.49 | 2021 | |
| Flower Orthopedics Coporation | $15.57 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Niraj Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.